Floatz logo

Tesamorelin

Abdominal Obesity

Massachusetts General Hospitalprotein_peptidePhase 2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Abdominal Obesity cohort.

Asset / SponsorPhaseRating
Hydrochlorothiazide
UMC Utrecht
Phase 4BBB
Moxonidine
Baker Heart and Diabetes Institute
Phase 4BB
Elafibranor
Genfit
Phase 2BB
UMBELLATINE
China National Center for Cardiovascular Diseases
Phase 4BB
Irbesartan
Baker Heart and Diabetes Institute
Phase 4BB

View all 27 →

Same molecule, other indications

Tesamorelin is also rated in:

lipodystrophyDormant
B
Indicative ·
62 / 100
View asset →
Body CompositionDormant
B
Indicative ·
60 / 100
View asset →
isolated congenital growth hormone deficiencyDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →